Master of Biotechnology

2 Years On Campus Masters Program

Monash University

Program Overview

The Master of Biotechnology (M6030) combines advanced medical biotechnology with entrepreneurship, research and industry experience, making it ideal for science graduates who want to translate laboratory discoveries into real biomedical products and technologies. Students study areas including genomics, proteomics, bioinformatics, regenerative medicine, gene and cell therapies, therapeutic development, genetics and biotechnology commercialisation.

Curriculum Structure

Year 1:
Students build their scientific and commercial foundations through BRM5011 Foundations for Medical Biotechnology and its Applications, BRM5012 Techniques in Medical Biotechnology: Genomics, Proteomics and Bioinformatics, and BRM5013 Techniques in Medical Biotechnology: Imaging, iPS Cells, Cell and Gene Therapies. The curriculum also includes BRM5014 Therapeutic Approaches and Biotechnology, BRM5015 Biotechnology Research Studies, GNA5010 Advanced Genetics and Biotechnology, and BMS5007 Biotechnology: Commercialising Biomedical Science, connecting scientific discovery with regulation, funding, entrepreneurship and commercialisation.

Year 2:
Students entering the full 96-credit-point, 2-year pathway progress into applied biotechnology. Those achieving at least a 70% average in Part A can apply for either the BRM5021 Biotechnology Research Project, a substantial research pathway, or BRM5022 Biotechnology Work-Integrated Learning, which combines a six-month industry placement with further electives; students who do not meet the 70% threshold complete approved coursework electives instead.

Note: The course can be completed in 1 or 2 years full-time depending on previous qualifications. Entry Level 2 students complete only the 48-credit-point Part A and therefore do not undertake the research project or industry placement component.

Learning outcomes: Apply advanced medical biotechnology knowledge | Use laboratory-based biotechnology techniques | Analyse and interpret biotechnology data | Understand product development, regulation and commercialisation | Evaluate ethical issues | Design and implement research | Solve practical biotechnology challenges | Apply effective teamwork and communication skills in professional settings.

Professional alignment (accreditation): Monash does not list a separate external professional accreditation for the Master of Biotechnology. Professional preparation instead comes through advanced technical training, biotechnology commercialisation, regulatory knowledge, research experience and the optional six-month industry placement embedded in the 2-year pathway.

Reputation: Monash University is ranked #31 globally in the QS World University Rankings 2027. It is also ranked #26 globally and #3 in Australia for Life Sciences and Medicine in the QS World University Rankings by Subject 2026, placing biotechnology students within one of Australia's strongest life-sciences environments.

Experiential Learning (Research, Projects, Internships etc.)

Practical training is built directly into the degree through laboratory-based biotechnology subjects, bioinformatics analysis, regenerative medicine techniques and either research or professional industry experience. Students gain hands-on exposure to imaging, cell reprogramming, microscopy, immunofluorescence, genome editing and high-throughput biological data, while eligible students can spend six months applying these skills within a biotechnology-related organisation.

Students can build their practical expertise through:

Six-month industry placement: BRM5022 Biotechnology Work-Integrated Learning places eligible students with an industry partner for approximately 24 weeks, normally involving 30–40 hours per week in the professional environment. Students apply biotechnology knowledge to industry challenges and complete supervisor reports, reflective work, a professional portfolio and an oral presentation.
Named placement organisations: Monash identifies organisations including Aeterna Health, CCRM, St Vincent’s Hospital Melbourne, Magic Valley and Western Health as examples of biotechnology-related placement environments spanning clinical trials, pharmaceuticals, medical devices and regulatory work.
Biotechnology Research Project: Eligible students can choose the 48-credit-point BRM5021 Biotechnology Research Project, working with specialists in medical biotechnology or regenerative medicine and investigating human disease and potential therapeutic targets.
Imaging and regenerative medicine: BRM5013 gives students hands-on training in non-invasive imaging, microscopy, immunofluorescence, cell reprogramming and genome-editing approaches, including work involving induced pluripotent stem cells.
Bioinformatics and genomic analysis: BRM5012 covers genomics, transcriptomics, proteomics, metabolomics and systems biology. Students develop experience using bioinformatics software, genome browsers and biological databases, including basic command-line coding for running analytical tools.
Australian Regenerative Medicine Institute (ARMI): Students learn within an environment connected to ARMI, which Monash describes as a world leader in regenerative biology.
FishCore: Monash identifies FishCore as the Southern Hemisphere's largest zebrafish research facility, supporting advanced biological and regenerative-medicine research.
Micromon: Students are exposed to an environment supported by Micromon, which provides genomics, proteomics and molecular biology services.
Monash Micro Imaging: This facility provides state-of-the-art biomedical imaging technology, supporting advanced imaging-based biotechnology and research applications.
Monash Technology Precinct: The Clayton campus is located within the Monash Technology Precinct, surrounded by biotechnology and research infrastructure including CSIRO and the Australian Synchrotron, creating strong links between science, engineering, medical research and commercialisation.
Commercialisation and entrepreneurship: Through subjects such as BMS5007 Biotechnology: Commercialising Biomedical Science and entrepreneurship electives, students explore how biotechnology discoveries progress through funding, intellectual property, regulation and market development.

Software and digital tools: The course specifically develops experience with bioinformatics software, genomic databases, genome browsers and command-line analysis. Monash does not prescribe one commercial software platform for the entire degree, as tools vary according to the unit, research project and placement.

Progression & Future Opportunities

Graduates are prepared for biotechnology careers spanning research, biopharmaceuticals, regenerative medicine, medical devices, diagnostics, pharmaceutical development, clinical trials, regulation and biotechnology commercialisation. Typical roles aligned with these official career areas include Biotechnology Scientist, Research Scientist, Clinical Trials Professional and Regulatory Affairs Associate, with additional opportunities in product development, intellectual property and start-ups.

The course supports the transition into employment through:

CareerEdge: Monash's CareerEdge provides personalised career support including resumé development, simulated interviews, career counselling and networking preparation tailored to individual career goals.
Careers and Internships Studio: Students at Clayton can access in-person career sessions covering application preparation, interview skills, employer expectations, networking and researching career pathways.
Monash Opportunities and Jobs Board: Students can access curated opportunities including internships, graduate programs, part-time work, volunteering, scholarships and leadership opportunities.
Industry experience: Eligible students can undertake the six-month BRM5022 biotechnology placement, providing direct professional experience and opportunities to develop industry networks before graduation.
Specific industry connections: Course-specific placement environments listed by Monash include Aeterna Health, CCRM, St Vincent’s Hospital Melbourne, Magic Valley and Western Health.
Professional portfolio: The WIL unit requires students to construct a professional portfolio, communicate solutions to industry challenges and reflect on their professional development, strengthening preparation for graduate recruitment.
Entrepreneurship and commercialisation: The program builds knowledge relevant to biotechnology start-ups, intellectual property, product development, regulation and commercialisation, supporting careers beyond laboratory research alone.
Graduate career sectors: Monash officially identifies opportunities in biotechnology and biopharma companies, medical device and diagnostics firms, pharmaceutical development, regenerative medicine and cell therapy, start-ups, intellectual-property and patent offices, clinical trials, regulatory agencies, research institutes and academic laboratories.
Long-term professional value: Although the course is not listed as an externally accredited registration qualification, its combination of technical biotechnology training, commercial knowledge, research and work-integrated learning provides strong preparation for scientific and industry careers.
Employment and salary figures: Monash currently does not publish an M6030-specific graduate employment percentage or median salary figure on the official course page, so a specific salary or employment rate should not be presented as an official program outcome.

Further Academic Progression:
Students who achieve the required academic standard can undertake the BRM5021 Biotechnology Research Project. Monash explicitly states that the research stream provides a pathway to a Doctor of Philosophy (PhD), making the degree particularly suitable for students who want to progress into advanced research in regenerative medicine, medical biotechnology, genomics, cell biology or related fields.